Company news
Arctic Bioscience As (OSL:ABS) news
Arctic Bioscience As news releases on 6ix. Latest, Aug 27, 2026: Arctic Bioscience - Strong revenue growth and new data on HRO350 complementing the HeROPA…
Press releases & updates
Arctic Bioscience - Strong revenue growth and new data on HRO350 complementing the HeROPA trial results
August 27, 2026
Arctic Bioscience presents HeROPA data at EADV in Athens
May 8, 2026
Arctic Bioscience : Consolidated 2025 Annual Report
May 7, 2026
Arctic Bioscience - Annual report 2025
May 7, 2026
Arctic Bioscience : Presentation of Q1-2026 update
April 30, 2026
Arctic Bioscience - 78% growth in Nutra revenues
April 30, 2026
Arctic Bioscience - Invitation to presentation of Q1 2026 operational update
April 24, 2026
Arctic Bioscience - Primary insiders who have provided bank guarantee
April 1, 2026
Arctic Bioscience - New long-term financing
April 1, 2026
Arctic Bioscience - New peer-reviewed study shows herring roe phospholipids stimulate anti-inflammatory pathways in cells
March 19, 2026
Arctic Bioscience : Presentation of Q4-2025 update
February 26, 2026
Arctic Bioscience - Q4 2025 Operational update - Positive outlook for 2026
February 26, 2026
Arctic Bioscience - Invitation to presentation of Q4 2025 operational update
February 23, 2026
Arctic Bioscience - Share capital increase registered
December 17, 2025
Arctic Bioscience - Board approval of share capital increase related to conversion of debt
December 12, 2025
Arctic Bioscience - Exercise of right to convert debt and issuance of shares
December 9, 2025
Arctic Bioscience - Q3 2025 Operational update - Significant results on systemic inflammation
November 10, 2025
Arctic Bioscience - Invitation to presentation of Q3 operational update and HeROPA-analyses results
November 7, 2025
Arctic Bioscience - Analysis on HeROPA study shows statistically significant effects of psoriasis drug candidate HRO350 on inflammation
November 4, 2025